Brighton Jones LLC’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $318K | Buy |
10,765
+90
| +0.8% | +$2.66K | 0.01% | 698 |
|
|
2025
Q1 | $319K | Buy |
10,675
+22
| +0.2% | +$657 | 0.01% | 512 |
|
|
2024
Q4 | $305K | Sell |
10,653
-29
| -0.3% | -$831 | 0.01% | 513 |
|
|
2024
Q3 | $413K | Buy |
10,682
+11
| +0.1% | +$425 | 0.02% | 357 |
|
|
2024
Q2 | $344K | Sell |
10,671
-100
| -0.9% | -$3.22K | 0.01% | 441 |
|
|
2024
Q1 | $418K | Buy |
10,771
+129
| +1% | +$5.01K | 0.02% | 388 |
|
|
2023
Q4 | $328K | Hold |
10,642
| – | – | 0.01% | 425 |
|
|
2023
Q3 | $238K | Hold |
10,642
| – | – | 0.01% | 459 |
|
|
2023
Q2 | $229K | Hold |
10,642
| – | – | 0.01% | 469 |
|
|
2023
Q1 | $255K | Hold |
10,642
| – | – | 0.01% | 417 |
|
|
2022
Q4 | $247K | Hold |
10,642
| – | – | 0.01% | 386 |
|
|
2022
Q3 | $170K | Buy |
10,642
+49
| +0.5% | +$783 | 0.01% | 432 |
|
|
2022
Q2 | $188K | Sell |
10,593
-63
| -0.6% | -$1.12K | 0.01% | 436 |
|
|
2022
Q1 | $217K | Buy |
10,656
+41
| +0.4% | +$835 | 0.01% | 456 |
|
|
2021
Q4 | $198K | Buy |
10,615
+22
| +0.2% | +$410 | 0.01% | 501 |
|
|
2021
Q3 | $209K | Hold |
10,593
| – | – | 0.01% | 447 |
|
|
2021
Q2 | $250K | Hold |
10,593
| – | – | 0.01% | 398 |
|
|
2021
Q1 | $251K | Buy |
+10,593
| New | +$251K | 0.01% | 351 |
|